Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata

Human Reproduction

Volumn 21, Issue 1, 2006, Pages 57-67

  Wei, Jian Jun ^a,b   Chiriboga, Luis ^a   Arslan, Alan A ^a   Melamed, Jonathan ^a   Yee, Herman ^a   Mittal, Khush ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Ethnicity; Immunohistochemistry; Leiomyoma; Nuclear receptors; Tissue microarray

Indexed keywords

CD24 ANTIGEN; CELL NUCLEUS RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HAMARTIN; PROGESTERONE RECEPTOR A; RETINOID; RETINOID X RECEPTOR ALPHA; SEX HORMONE; SOMATOMEDIN; SOMATOMEDIN B; TUBERIN;

ADULT; ARTICLE; ASIAN; CAUCASIAN; CELL PROLIFERATION; CLUSTER ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; ETHNIC DIFFERENCE; HISPANIC; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYOMETRIUM; NEGRO; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; UPREGULATION; UTERUS MYOMA;

EID: 29144520613     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei309     Document Type: Article

References (39)

1. Ahn, WS, Kim, KW Bae SM, Yoon JH, Lee JM, Namkoong SE, Kim JH, Kim CK, Lee YJ and Kim YW (2003) Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis. Int J Exp Pathol 846,267-279.
2. Amant F, Huys E, Geurts-Moespot A, Lindeque BG, Vergote I, Sweep F and Schoenmakers EF (2003) Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels. J Soc Gynecol Invest 102,105-109.
3. Arslan AA, Gold LI, Mittal K, Suen TC, Belitskaya-Levy I, Tang MS and Toniolo P (2005) Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: New evidence and a systematic review. Hum Reprod 204,852-863.
4. Catherino WH, Prupas C, Tsibris JC, Leppert PC, Payson M, Nieman LK and Segars JH (2003) Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. Fertil Steril 802,282-290.
5. Chegini N, Verala J, Luo X, Xu J and Williams RS (2003) Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Invest 103,161-171.
6. Baird DD, Dunson DB, Hill MC, Cousins D and Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 1881,100-107.
7. Di Lieto A, De Rosa G, De Falco M, Iannotti F, Staibano S, Pollio F, Scaramellino M and Salvatore G (2002) Relationship between plateletderived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment. Hum Pathol 332,220-224.
8. Dixon D, He H and Haseman JK (2000) Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ Health Perspect 108(Suppl 5)795-802.
9. Duester G (1996) Involvement of alcohol dehydrogenase, short-chain dehydrogenase/reductase, ldehyde dehydrogenase and cytochrome P450 in the control of retinoid signaling by activation of retinoic acid synthesis. Biochemistry 3538,12221-12227.
10. Eisen MB, Spellman PT, Brown PO and Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95,14863-14868.
11. Flake GP, Andersen J and Dixon D (2003) Etiology and pathogenesis of uterine leiomyomas: A review. Environ Health Perspect 1118,1037-1054.
12. Gamage SD, Bischoff ED, Burroughs KD, Lamph WW, Gottardis MM, Walker CL and Fuchs-Young R (2000) Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma. J Pharmacol Exp Ther 295,677-681.
13. Gao X and Pan D (2001) TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev 15,1383-1392.
14. Gross, KL, Neskey DM, Manchanda N, Weremowicz S, Kleinman MS, Nowak RA, Ligon AH, Rogalla P, Drechsler K, Bullerdiek J and Morton CC (2003) HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies. Genes Chromosomes Cancer 38,68-79.
15. Hoffman PJ, Milliken DB, Gregg LC, Davis RR and Gregg JP (2004) Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertil Steril 82,639-649.
16. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM and Walker CL (2003) Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma. Cancer Res 636,1221-1227.
17. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD and Guzinski GM (1996) Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41,483-490.
18. Kovacs KA, Lengyel F, Kornyei JL, Vertes Z, Szabo I, Sumegi B and Vertes M (2003) Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium. J Steroid Biochem Mol Biol 87,233-240.
19. Liu CL, Prapong W, Natkunam Y, Alizadeh A, Montgomery K, Gilks CB and van de Rijn M (2002) Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161,1557-1565.
20. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, Willett WC and Hunter DJ (1997) Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90,967-973.
21. Martin Chaves EB, Brum IS, Stoll J, Capp E and Corleta HE (2004) Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma. Gynecol Obstet Invest 57,210-213.
22. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K and Takashima S (1996) Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol 40,941-4.
23. Nisolle M, Gillerot S, Casanas-Roux F, Squifflet J, Berliere M and Donnez J (1999) Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy. Hum Reprod 14,2844-2850.
24. Noe M, Kunz G, Herbertz M, Mall G and Leyendecker G (1999) The cyclic pattern of the immunocytochemical expression of oestrogen and progesterone receptors in human myometrial and endometrial layers: characterization of the endometrial-subendometrial unit. Hum Reprod 14,190-197.
25. Pollak MN (2004) Insulin-like growth factors and neoplasia. Novartis Found Symp 262,84-98; discussion 98-107,265-268.
26. Potter CJ, Huang H and Xu T (2001) Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation and organ size. Cell 105,357-368.
27. Quade BJ, Wang TY, Sornberger K, Cin PD, Mutter GL and Morton CC (2004) Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer 40,97-108.
28. Sadan O, van Iddekinge B, Savage N, Robinson M and Zakut H (1988) Ethnic variation in estrogen and progesterone receptor concentration in leiomyoma and normal myometrium. Gynecol Endocrinol 2,275-282.
29. Skubitz KM and Skubitz AP (2003) Differential gene expression in uterine leiomyoma. J Lab Clin Med 141,297-308.
30. Tsibris JC, Porter KB, Jazayeri A, Tzimas G, Nau H, Huang H, Kuparadze K, Porter GW, O'Brien WF and Spellacy WN (1999) Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha and all-trans retinoic acid than myometrium. Cancer Res 59,5737-5744.
31. Tsibris JC, Segars J, Coppola D, Mane S, Wilbanks GD, O'Brien WF and Spellacy WN (2002) Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 78,114-121.
32. Varol N, Healey M, Tang P, Sheehan P, Maher P and Hill D (2001) Ten-year review of hysterectomy morbidity and mortality: Can we change direction? Aust NZ J Obstet Gynaecol 41,295-302.
33. Wang H, Mahadevappa M, Yamamoto K, Wen Y, Chen B, Warrington JA and Polan ML (2003) Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril 80,266-276.
34. Wei J, Chiriboga L, Mizuguchi M, Yee H and Mittal K (2005a) Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata. Mod Pathol 18,179-188.
35. Wei J, Chiriboga L and MK (2005b) Expression profile of the tumorigenic factors in association with tumor size and sex steroid hormone status in uterine leiomyomata. Fertil Steril 84,474-484.
36. Weston G, Trajstman AC, Gargett CE, Manuelpillai U, Vollenhoven BJ and Rogers PA (2003) Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod 9,541-549.
37. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z and Peterson HB (1994) Hysterectomy in the United States, 1988-1990. Obstet Gynecol 83,549-555.
38. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL and Rosenberg L (2004a) Reproductive factors, hormonal contraception and risk of uterine leiomyomata in African-American women: A prospective study. Am J Epidemiol 159,113-123.
39. Woods MN, Barnett JB, Spiegelman D, Trail N, Hertzmark E, Longcope C and Gorbach SL (1996) Hormone levels during dietary changes in premenopausal African-American women. J Natl Cancer Inst 88,1369-1374.